フェノバルビタールの世界市場レポート 2025年

フェノバルビタールの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.2％で19億1,000万米ドルに成長します。予測期間中の成長は、ジェネリック医薬品製造の拡大、神経疾患管理への注目の高まり、デジタルサプライチェーンとe-pharmacyの成長、ジェネリック医薬品使用を支持する規制の変更、ジェネリック医薬品の規制経路の安定性と関連付けることができます。予測期間における主な動向としては、投与しやすいデリバリー形態の開発、研究開発におけるイノベーション、徐放性製剤、強化型ドラッグデリバリーシステム、生産技術向上への投資などが挙げられます。

てんかんの有病率の増加は、フェノバルビタール市場の成長を牽引すると予測されます。てんかんは、脳の異常な活動によって引き起こされる誘発性のない発作を繰り返す神経疾患です。てんかんの罹患率が増加している背景には、認知度の向上もあり、症状を認識して医療機関を受診する人が増え、その結果、報告症例が増加していることがあります。抗けいれん薬であるフェノバルビタールは、脳内の神経細胞の活動を鈍らせることで発作を抑制します。例えば、米国疾病予防管理センター（CDC）が2024年5月に発表した報告書によると、2021年から2022年の間に、米国では約290万人の成人が活動性てんかんと共存しており、これは成人人口の約1％に相当します。その結果、てんかんの有病率の増加がフェノバルビタールの需要を牽引すると予想されます。

フェノバルビタール市場の主な企業は、フェノバルビタールナトリウムのような新しい治療法の開発に注力し、治療の安全性と有効性の両方を向上させています。フェノバルビタールナトリウムはフェノバルビタールのナトリウム塩であり、一般的に抗けいれん薬や鎮静薬として使用されています。主にてんかんなどの発作の管理に処方され、不安や不眠症の治療、医療処置前の鎮静にも使用されます。2023年1月、インドを拠点とする製薬会社Sun Pharmaceutical Industries Ltd.は、米国でSEZABYを発売しました。これはFDAが承認した初めての薬で、学期末および早産の新生児の発作を治療するために特別に設計されました。SEZABYはベンジルアルコールとプロピレングリコールを含まないため、新生児への使用がより安全です。本薬は希少疾病用医薬品の指定を受け、新生児発作のコントロールに有効であることを示す臨床データによって裏付けられており、この脆弱な患者群における重要なアンメットニーズに対応しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のフェノバルビタールPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のフェノバルビタール市場：成長率分析
• 世界のフェノバルビタール市場の実績：規模と成長, 2019-2024
• 世界のフェノバルビタール市場の予測：規模と成長, 2024-2029, 2034F
• 世界のフェノバルビタール総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のフェノバルビタール市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• てんかん
• 新生児発作
• 世界のフェノバルビタール市場：剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤
• カプセル
• 注射剤
• 世界のフェノバルビタール市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のフェノバルビタール市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 発作管理
• 麻酔
• 睡眠障害
• アルコール離脱症候群
• 世界のフェノバルビタール市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 研究ラボ
• 在宅ケア環境
• 世界のフェノバルビタール市場、てんかん、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所（部分）発作
• 全般性強直間代発作
• てんかん重積状態
• 難治性てんかん
• 特発性てんかん
• 世界のフェノバルビタール市場、新生児発作、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 低酸素性虚血性脳症（HIE）誘発性発作
• 頭蓋内出血誘発性発作
• 代謝障害
• 先天性脳奇形
• 感染症

第7章 地域別・国別分析

• 世界のフェノバルビタール市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のフェノバルビタール市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• フェノバルビタール市場：競合情勢
• フェノバルビタール市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Ltd.
• Fresenius Kabi AG
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories Ltd.
• Lupin Limited
• H. Lundbeck A/S
• Sandoz Group AG
• Yashiro Pharmaceutical Co. Ltd.
• Hikma Pharmaceuticals PLC
• Par Pharmaceutical Inc.
• Shandong Xinhua Pharmaceutical Co. Ltd.
• Manus Aktteva Biopharma LLP
• JPN Pharma Pvt. Ltd.
• Alkaloida Chemical Company Zrt.
• Harman Finochem Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• フェノバルビタール市場2029：新たな機会を提供する国
• フェノバルビタール市場2029：新たな機会を提供するセグメント
• フェノバルビタール市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Phenobarbital is a long-acting barbiturate medication primarily used to control and prevent seizures, especially in the treatment of epilepsy. It is occasionally prescribed as a sedative for anxiety or to manage withdrawal symptoms. It works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits nerve activity in the brain, leading to a calming effect on the central nervous system and a reduced risk of seizures.

The main indications for phenobarbital are epilepsy and neonatal seizures. Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures. It is available in various dosage forms such as tablets, capsules, and injectables, and is distributed through hospital pharmacies, retail pharmacies, and online pharmacies. It is used in seizure management, anesthesia, sleep disorders, and alcohol withdrawal syndrome, serving a range of end users, including hospitals, clinics, research laboratories, and homecare settings.

The phenobarbital market research report is one of a series of new reports from The Business Research Company that provides phenobarbital market statistics, including phenobarbital industry global market size, regional shares, competitors with a phenobarbital market share, detailed phenobarbital market segments, market trends and opportunities, and any further data you may need to thrive in the phenobarbital industry. This phenobarbital market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The phenobarbital market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to the widespread use in epilepsy management, the prevalence of epilepsy and seizure disorders, government supply programs, increasing demand in veterinary applications, and efforts toward achieving universal health coverage.

The phenobarbital market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth during the forecast period can be linked to the expansion of generic drug manufacturing, growing focus on neurological disease management, digital supply chain and e-pharmacy growth, regulatory changes favoring generic use, and stability in regulatory pathways for generics. Key trends in the forecast period include the development of easy-to-administer delivery forms, innovation in research and development, extended-release formulations, enhanced drug delivery systems, and investments in improving production techniques.

The rising prevalence of epilepsy is anticipated to drive the growth of the phenobarbital market. Epilepsy is a neurological condition marked by recurring, unprovoked seizures caused by abnormal brain activity. The increasing incidence of epilepsy is partly due to greater awareness, leading more individuals to recognize symptoms and seek medical attention, resulting in more reported cases. Phenobarbital, an anticonvulsant medication, helps control seizures by slowing down the activity of neurons in the brain. For example, a report from the Centers for Disease Control and Prevention (CDC) in May 2024 revealed that between 2021 and 2022, around 2.9 million adults in the U.S. were living with active epilepsy, representing approximately 1% of the adult population. As a result, the growing prevalence of epilepsy is expected to drive the demand for phenobarbital.

Key companies in the phenobarbital market are focusing on developing new treatments, such as phenobarbital sodium, to improve both the safety and effectiveness of therapies. Phenobarbital sodium is the sodium salt form of phenobarbital, commonly used as an anticonvulsant and sedative. It is primarily prescribed to manage seizures, especially in conditions such as epilepsy, and can also be used to treat anxiety, insomnia, and to induce sedation before medical procedures. In January 2023, Sun Pharmaceutical Industries Ltd., an India-based pharmaceutical company, launched SEZABY (phenobarbital sodium) in the U.S. This was the first FDA-approved medication specifically designed to treat seizures in both term and preterm neonates. SEZABY is free of benzyl alcohol and propylene glycol, making it safer for use in newborns. The drug received orphan drug designation and is supported by clinical data demonstrating its effectiveness in controlling neonatal seizures, addressing a critical unmet need in this vulnerable patient group.

In November 2022, Sun Pharmaceutical Industries Ltd. partnered with SPARC, an India-based biopharmaceutical company, to commercialize phenobarbital for injection in the U.S. This collaboration focuses on marketing a benzyl alcohol- and propylene glycol-free phenobarbital sodium injection to address the unmet need for an FDA-approved treatment for neonatal seizures, while also reducing the risk of neonatal gasping syndrome. SPARC specializes in developing innovative therapeutics.

Major players in the phenobarbital market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, H. Lundbeck A/S, Sandoz Group AG, Yashiro Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Par Pharmaceutical Inc., Shandong Xinhua Pharmaceutical Co. Ltd., Manus Aktteva Biopharma LLP, JPN Pharma Pvt. Ltd., Alkaloida Chemical Company Zrt., Harman Finochem Ltd.

North America was the largest region in the phenobarbital market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in phenobarbital report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the phenobarbital market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The phenobarbital market consists of sales of products including phenobarbital tablets, phenobarbital oral elixir, phenobarbital injectables, veterinary phenobarbital products, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Phenobarbital Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on phenobarbital market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for phenobarbital ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The phenobarbital market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Indication: Epilepsy; Neonatal Seizures
• 2) By Dosage Forms: Tablets; Capsules; Injectables
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By Application: Seizure Management; Anesthesia; Sleep Disorders; Alcohol Withdrawal Syndrome
• 5) By End User: Hospitals; Clinics; Research Laboratories; Homecare Settings
• Subsegments:
• 1) By Epilepsy: Focal (Partial) Seizures; Generalized Tonic-Clonic Seizures; Status Epilepticus; Refractory Epilepsy; Idiopathic Epilepsy
• 2) By Neonatal Seizures: Hypoxic-Ischemic Encephalopathy (HIE)-Induced Seizures; Intracranial Hemorrhage-Induced Seizures; Metabolic Disorders; Congenital Brain Malformations; Infections
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Eli Lilly and Company; Baxter International Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Phenobarbital Market Characteristics

3. Phenobarbital Market Trends And Strategies

4. Phenobarbital Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Phenobarbital Growth Analysis And Strategic Analysis Framework

• 5.1. Global Phenobarbital PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Phenobarbital Market Growth Rate Analysis
• 5.4. Global Phenobarbital Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Phenobarbital Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Phenobarbital Total Addressable Market (TAM)

6. Phenobarbital Market Segmentation

• 6.1. Global Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epilepsy
• Neonatal Seizures
• 6.2. Global Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Injectables
• 6.3. Global Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Phenobarbital Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Seizure Management
• Anesthesia
• Sleep Disorders
• Alcohol Withdrawal Syndrome
• 6.5. Global Phenobarbital Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Laboratories
• Homecare Settings
• 6.6. Global Phenobarbital Market, Sub-Segmentation Of Epilepsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Focal (Partial) Seizures
• Generalized Tonic-Clonic Seizures
• Status Epilepticus
• Refractory Epilepsy
• Idiopathic Epilepsy
• 6.7. Global Phenobarbital Market, Sub-Segmentation Of Neonatal Seizures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypoxic-Ischemic Encephalopathy (HIE)-Induced Seizures
• Intracranial Hemorrhage-Induced Seizures
• Metabolic Disorders
• Congenital Brain Malformations
• Infections

7. Phenobarbital Market Regional And Country Analysis

• 7.1. Global Phenobarbital Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Phenobarbital Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Phenobarbital Market

• 8.1. Asia-Pacific Phenobarbital Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Phenobarbital Market

• 9.1. China Phenobarbital Market Overview
• 9.2. China Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Phenobarbital Market

• 10.1. India Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Phenobarbital Market

• 11.1. Japan Phenobarbital Market Overview
• 11.2. Japan Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Phenobarbital Market

• 12.1. Australia Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Phenobarbital Market

• 13.1. Indonesia Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Phenobarbital Market

• 14.1. South Korea Phenobarbital Market Overview
• 14.2. South Korea Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Phenobarbital Market

• 15.1. Western Europe Phenobarbital Market Overview
• 15.2. Western Europe Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Phenobarbital Market

• 16.1. UK Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Phenobarbital Market

• 17.1. Germany Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Phenobarbital Market

• 18.1. France Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Phenobarbital Market

• 19.1. Italy Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Phenobarbital Market

• 20.1. Spain Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Phenobarbital Market

• 21.1. Eastern Europe Phenobarbital Market Overview
• 21.2. Eastern Europe Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Phenobarbital Market

• 22.1. Russia Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Phenobarbital Market

• 23.1. North America Phenobarbital Market Overview
• 23.2. North America Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Phenobarbital Market

• 24.1. USA Phenobarbital Market Overview
• 24.2. USA Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Phenobarbital Market

• 25.1. Canada Phenobarbital Market Overview
• 25.2. Canada Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Phenobarbital Market

• 26.1. South America Phenobarbital Market Overview
• 26.2. South America Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Phenobarbital Market

• 27.1. Brazil Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Phenobarbital Market

• 28.1. Middle East Phenobarbital Market Overview
• 28.2. Middle East Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Phenobarbital Market

• 29.1. Africa Phenobarbital Market Overview
• 29.2. Africa Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Phenobarbital Market Competitive Landscape And Company Profiles

• 30.1. Phenobarbital Market Competitive Landscape
• 30.2. Phenobarbital Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Phenobarbital Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Fresenius Kabi AG
• 31.3. Sun Pharmaceutical Industries Ltd.
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Lupin Limited
• 31.6. H. Lundbeck A/S
• 31.7. Sandoz Group AG
• 31.8. Yashiro Pharmaceutical Co. Ltd.
• 31.9. Hikma Pharmaceuticals PLC
• 31.10. Par Pharmaceutical Inc.
• 31.11. Shandong Xinhua Pharmaceutical Co. Ltd.
• 31.12. Manus Aktteva Biopharma LLP
• 31.13. JPN Pharma Pvt. Ltd.
• 31.14. Alkaloida Chemical Company Zrt.
• 31.15. Harman Finochem Ltd.

32. Global Phenobarbital Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Phenobarbital Market

34. Recent Developments In The Phenobarbital Market

35. Phenobarbital Market High Potential Countries, Segments and Strategies

• 35.1 Phenobarbital Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Phenobarbital Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Phenobarbital Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer